Advanced search
Publication Cover
OncoImmunology Volume 10, 2021 - Issue 1
Submit an article Journal homepage
2,144
Views
8
CrossRef citations to date
0
Altmetric
Prognostic biomarker

Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma

Azaz Ahmeda Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University Heidelberg, Heidelberg, Germany;b Translational Immunotherapy, German Cancer Research Center (DKFZ), Heidelberg, GermanyView further author information
,
Sophia Köhlera Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University Heidelberg, Heidelberg, GermanyView further author information
,
Rosa Klotzc General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University Heidelberg, Heidelberg, GermanyView further author information
,
Nathalia Giesec General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University Heidelberg, Heidelberg, GermanyView further author information
,
Felix Lasitschkad Institute of Pathology, University Hospital Heidelberg, University Heidelberg, Heidelberg, GermanyView further author information
,
Thilo Hackertc General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University Heidelberg, Heidelberg, GermanyView further author information
,
Christoph Springfelda Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University Heidelberg, Heidelberg, GermanyView further author information
,
Inka Zörniga Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University Heidelberg, Heidelberg, GermanyView further author information
,
Dirk Jägera Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University Heidelberg, Heidelberg, Germany;e Applied Tumor Immunity Clinical Cooperation Unit, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, GermanyView further author information
&
Niels Halamaa Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University Heidelberg, Heidelberg, Germany;b Translational Immunotherapy, German Cancer Research Center (DKFZ), Heidelberg, GermanyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0344-6027View further author information
ORCID Icon show all
Article: 1962135 | Received 12 May 2021, Accepted 24 Jul 2021, Published online: 10 Aug 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.